Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Acceptability of Dispensing Mifepristone Via Mail Order Pharmacy

NCT03913104 is registered in ClinicalTrials.gov with Daniel Grossman, MD as lead sponsor.

NCT NCT03913104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03913104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Acceptability of Dispensing Mifepristone Via Mail Order Pharmacy
Lead sponsor
Daniel Grossman, MD
Phase
Phase 4
Overall status
Completed
Start date
January 5, 2020
Completion date
July 30, 2023
Enrollment
536 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

abortion early, pregnancy related